These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1311469)

  • 1. Inhibition of CD27 expression by cyclosporine A; role of IL-2.
    Martorell J; Martinez-Caceres E; Rojo I; Vives J
    Transplant Proc; 1992 Feb; 24(1):125. PubMed ID: 1311469
    [No Abstract]   [Full Text] [Related]  

  • 2. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions.
    Sugita K; Hirose T; Rothstein DM; Donahue C; Schlossman SF; Morimoto C
    J Immunol; 1992 Nov; 149(10):3208-16. PubMed ID: 1358967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
    Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
    Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD27 induction on thymocytes.
    Martorell J; Rojo I; Vilella R; Martinez-Caceres E; Vives J
    J Immunol; 1990 Sep; 145(5):1356-63. PubMed ID: 1974563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1A4 molecule (CD27) is involved in T cell activation.
    Sugita K; Torimoto Y; Nojima Y; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Sep; 147(5):1477-83. PubMed ID: 1715359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells.
    Sugita K; Robertson MJ; Torimoto Y; Ritz J; Schlossman SF; Morimoto C
    J Immunol; 1992 Aug; 149(4):1199-203. PubMed ID: 1354231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells.
    Schwinzer R; Franklin RA; Domenico J; Renz H; Gelfand EW
    J Immunol; 1992 Mar; 148(5):1322-8. PubMed ID: 1371524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro expression of activation markers and lymphocyte proliferation in response to interleukin 12: effect of immunosuppressive agents.
    Degiannis D; Koniavitou K
    Transplant Proc; 1996 Dec; 28(6):3062-4. PubMed ID: 8962187
    [No Abstract]   [Full Text] [Related]  

  • 10. Maturation- and differentiation-dependent responsiveness of human CD4+ T helper subsets.
    de Jong R; Brouwer M; Kuiper HM; Hooibrink B; Miedema F; van Lier RA
    J Immunol; 1992 Oct; 149(8):2795-802. PubMed ID: 1328387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset.
    Maurer D; Fischer GF; Fae I; Majdic O; Stuhlmeier K; Von Jeney N; Holter W; Knapp W
    J Immunol; 1992 Jun; 148(12):3700-5. PubMed ID: 1318333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes.
    Good MF; Powell LW; Halliday JW
    Immunology; 1989 Jun; 67(2):225-30. PubMed ID: 2568977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of CD27 expression on subsets of mature T-lymphocytes.
    Hintzen RQ; de Jong R; Lens SM; Brouwer M; Baars P; van Lier RA
    J Immunol; 1993 Sep; 151(5):2426-35. PubMed ID: 7689607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants.
    Vanhecke D; Leclercq G; Plum J; Vandekerckhove B
    J Immunol; 1995 Aug; 155(4):1862-72. PubMed ID: 7543535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of T cell proliferation by IL-7.
    Grabstein KH; Namen AE; Shanebeck K; Voice RF; Reed SG; Widmer MB
    J Immunol; 1990 Apr; 144(8):3015-20. PubMed ID: 1969881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.